About Actiza Pharmaceutical Private Limited
Data last updated:
Actiza Pharmaceutical Private Limited is a private limited company based in Surat, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2017PTC097875. Its GSTIN is 24AAPCA8809B1ZQ (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sanjay Gangani Rameshbhai and Nileshbhai Mendpara Vallabhbhai.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 309 Royal Square Near Utran Petrol Pump Utran, Surat, Gujarat, India – 394105.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.71 Cr, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹4.88 Lakh (net margin 0.9%) and EBITDA of ₹11.67 Lakh (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 21% over five years.
Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website actizapharma.com.
Company details
Contact details
Actiza Pharmaceutical Private Limited's registered office is in Surat, Gujarat. Its website is actizapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address309 Royal Square Near Utran Petrol Pump Utran, Surat, Gujarat, India – 394105
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Actiza Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Actiza Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Actiza Pharmaceutical Private Limited, buy the company report.
Financials of Actiza Pharmaceutical Private Limited
FY 2025 filings availableActiza Pharmaceutical Private Limited reported revenue of ₹5.71 Cr (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 23% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹11.67 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Actiza Pharmaceutical Private Limited, buy the company report.
Board of directors of Actiza Pharmaceutical Private Limited
Actiza Pharmaceutical has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Gangani Rameshbhai | Director | 14 Jun 2017 | 9 Years 4 Months | Current |
| Nileshbhai Mendpara Vallabhbhai | Director | 14 Jun 2017 | 9 Years 4 Months | Current |
| Milanbhai Sojitra Chhaganbhai | Director | 14 Jun 2017 | 9 Years 4 Months | Current |
Peer comparison
Actiza Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Drakt Pharmaceuticals Pvt Ltd | ₹5.75 Cr (FY 2019) | -24.0% | Kolkata, West Bengal, India | |||
| Ethidrugs Research Lab Private Limited | ₹5.74 Cr (FY 2025) | 22.0% | Puducherry, India | |||
| Actiza Pharmaceutical Private Limitedthis company | ₹5.71 Cr (FY 2025) | ₹4.88 Lakh | 0.9% | 23.0% | Surat, Gujarat, India | |
| Sowilo India Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | 35.0% | Delhi, India | |||
| Suyog Pharmaceuticals Private Limited | ₹5.69 Cr (FY 2025) | 25.0% | Thane, Maharashtra, India | |||
| Genova Biotechniques Private Limited | ₹5.69 Cr (FY 2025) | -6.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Actiza Pharmaceutical Private Limited, buy the company report.
Auditor
Actiza Pharmaceutical Private Limited is audited by DNY & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DNY & ASSOCIATES | FY 2022 | 0133553W |
Shareholding
The shareholding of Actiza Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Actiza Pharmaceutical Private Limited, buy the company report.
Legal cases
Actiza Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Pfizer Inc & Ors. | Disposed |
To see the full case history of Actiza Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Actiza Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Actiza Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAPCA8809B1ZQ | Gujarat | Active | 06 Sep 2017 |
To see the full GST registrations and return filing status of Actiza Pharmaceutical Private Limited, buy the company report.
Recent activity
Actiza Pharmaceutical Private Limited has 3 board changes on record since 2017: 3 appointments. The latest: Milanbhai Sojitra Chhaganbhai was appointed as Director on 14 Jun 2017.
Frequently asked questions
Actiza Pharmaceutical is an active private limited company based in Surat, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2017 (9+ years old) and is registered under CIN U74999GJ2017PTC097875.
Actiza Pharmaceutical has 3 current directors:
- Sanjay Gangani Rameshbhai - Director
- Nileshbhai Mendpara Vallabhbhai - Director
- Milanbhai Sojitra Chhaganbhai - Director
The latest financial statements of Actiza Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Actiza Pharmaceutical is 24AAPCA8809B1ZQ, registered in Gujarat.
The CIN (Corporate Identification Number) of Actiza Pharmaceutical is U74999GJ2017PTC097875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Actiza Pharmaceutical has 1 court case on record: 1 filed against it.
Actiza Pharmaceutical was incorporated on 14 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Actiza Pharmaceutical by revenue are Drakt Pharmaceuticals Pvt Ltd, Ethidrugs Research Lab Private Limited, Sowilo India Pharmaceuticals Private Limited, Suyog Pharmaceuticals Private Limited, Genova Biotechniques Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Milanbhai Sojitra Chhaganbhai was appointed as Director on 14 Jun 2017. Nileshbhai Mendpara Vallabhbhai was appointed as Director on 14 Jun 2017. Sanjay Gangani Rameshbhai was appointed as Director on 14 Jun 2017.
Actiza Pharmaceutical can be reached through the website actizapharma.com. Its registered office is in Surat, Gujarat, India.
The registered office of Actiza Pharmaceutical is at 309 Royal Square Near Utran Petrol Pump Utran, Surat, Gujarat, India – 394105.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
